Treatment continuation in patients receiving biological agents or conventional DMARD therapy.
Zink A; Listing J; Kary S; Ramlau P; Stoyanova-Scholz M; Babinsky K; von Hinueber U; Gromnica-Ihle E; Wassenberg S; Antoni C; Herzer P; Kekow J; Schneider M; Rau R; Annals Of The Rheumatic Diseases, 2005, vol. 64, issue 9, p 1274, ISSN 00034967. ISBN 00034967.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef